Promising data from first 4 patients treated with BS-01 optogenetic gene therapy March 31, 2021 No Comments
ProQR plans phase II/III studies with QR-421a in Usher syndrome based on phase I/II trial analysis March 24, 2021 No Comments
Harbour begins phase III study in China of HBM-9036 for moderate to severe dry eye March 16, 2021 No Comments
FDA clears IND for izokibep as treatment of noninfectious nonanterior uveitis March 11, 2021 No Comments
Preliminary topline data reported from phase IIb ALTISSIMO study of GB-102 March 10, 2021 No Comments